IN2015DN01160A - - Google Patents
Info
- Publication number
- IN2015DN01160A IN2015DN01160A IN1160DEN2015A IN2015DN01160A IN 2015DN01160 A IN2015DN01160 A IN 2015DN01160A IN 1160DEN2015 A IN1160DEN2015 A IN 1160DEN2015A IN 2015DN01160 A IN2015DN01160 A IN 2015DN01160A
- Authority
- IN
- India
- Prior art keywords
- pylori
- stomach
- ppi
- therapy
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/732—Pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012137067/15A RU2501549C1 (ru) | 2012-08-30 | 2012-08-30 | Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни |
| PCT/RU2013/000738 WO2014035295A1 (ru) | 2012-08-30 | 2013-08-22 | Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN01160A true IN2015DN01160A (ru) | 2015-06-26 |
Family
ID=49785069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1160DEN2015 IN2015DN01160A (ru) | 2012-08-30 | 2015-02-12 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9713610B2 (ru) |
| EP (1) | EP2891483A4 (ru) |
| JP (1) | JP2015526512A (ru) |
| CN (1) | CN104602671A (ru) |
| CA (1) | CA2891457A1 (ru) |
| EA (1) | EA201500181A1 (ru) |
| IN (1) | IN2015DN01160A (ru) |
| PH (1) | PH12015500351A1 (ru) |
| RU (1) | RU2501549C1 (ru) |
| WO (1) | WO2014035295A1 (ru) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3335716A1 (en) * | 2016-12-15 | 2018-06-20 | Indena S.p.A. | Process for the preparation of powder compositions |
| CN108159059A (zh) * | 2017-12-15 | 2018-06-15 | 哈尔滨珍宝制药有限公司 | 一种包含埃索美拉唑钠的药物组合物及其制备方法 |
| RU2695067C1 (ru) * | 2019-04-30 | 2019-07-19 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" | Способ лечения дуоденогастроэзофагеального рефлюкса |
| US20220409646A1 (en) * | 2021-06-09 | 2022-12-29 | Isothrive Inc. | Maltosyl-isomalto-oligosaccharides reduce symptoms of gastroesophageal reflux disease |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994003184A1 (en) | 1992-07-31 | 1994-02-17 | Neose Pharmaceuticals, Inc. | Compositions for treating and inhibiting gastric and duodenal ulcers |
| US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| SE510666C2 (sv) | 1996-12-20 | 1999-06-14 | Astra Ab | Nya Kristallmodifikationer |
| JP2002501897A (ja) * | 1998-01-30 | 2002-01-22 | セプラコール， インク． | Ｒ−ランソプラゾール組成物及び方法 |
| WO1999059612A1 (en) | 1998-05-15 | 1999-11-25 | Aphton Corporation | Method for the treatment of gastroesophageal reflux disease |
| UA72748C2 (en) | 1998-11-10 | 2005-04-15 | Astrazeneca Ab | A novel crystalline form of omeprazole |
| WO2003053221A2 (en) | 2001-12-19 | 2003-07-03 | Eisai Co. Ltd | Methods using proton pump inhibitors |
| CN100558726C (zh) * | 2003-02-24 | 2009-11-11 | 田边三菱制药株式会社 | 泰妥拉唑的对映体及其在治疗中的应用 |
| TWI372066B (en) | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
| WO2005044199A2 (en) * | 2003-11-05 | 2005-05-19 | Santarus, Inc. | Combination of proton pump inhibitor and sleep aid |
| WO2005076987A2 (en) * | 2004-02-10 | 2005-08-25 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent |
| US20060165824A1 (en) | 2005-01-26 | 2006-07-27 | The Procter & Gamble Company | Compositions, kits, and methods for enhancing gastrointestinal health |
| CN101460183A (zh) * | 2006-04-10 | 2009-06-17 | 亚历山大·弗拉基米罗维奇·迪科夫斯基 | 肠道吸附剂和益生素组合物、用药形式及消化道紊乱的预防和治疗方法 |
| CN101317604B (zh) * | 2008-07-09 | 2011-07-20 | 内蒙古蒙牛乳业（集团）股份有限公司 | 一种添加益生元适合孕妇饮用的液态奶 |
| EP2208500A1 (en) | 2009-01-16 | 2010-07-21 | Bionap S.r.L. | Compositions for the treatment of gerd (gastroesophageal reflux disease) |
| RU2410100C2 (ru) * | 2009-03-30 | 2011-01-27 | Александр Владимирович Диковский | Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки |
-
2012
- 2012-08-30 RU RU2012137067/15A patent/RU2501549C1/ru active IP Right Revival
-
2013
- 2013-08-22 US US14/422,447 patent/US9713610B2/en active Active
- 2013-08-22 EA EA201500181A patent/EA201500181A1/ru unknown
- 2013-08-22 EP EP13832613.7A patent/EP2891483A4/en not_active Withdrawn
- 2013-08-22 CN CN201380042948.7A patent/CN104602671A/zh active Pending
- 2013-08-22 JP JP2015529748A patent/JP2015526512A/ja active Pending
- 2013-08-22 WO PCT/RU2013/000738 patent/WO2014035295A1/ru active Application Filing
- 2013-08-22 CA CA2891457A patent/CA2891457A1/en not_active Abandoned
-
2015
- 2015-02-12 IN IN1160DEN2015 patent/IN2015DN01160A/en unknown
- 2015-02-18 PH PH12015500351A patent/PH12015500351A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201500181A1 (ru) | 2015-05-29 |
| US20150202192A1 (en) | 2015-07-23 |
| RU2501549C1 (ru) | 2013-12-20 |
| WO2014035295A1 (ru) | 2014-03-06 |
| PH12015500351A1 (en) | 2015-04-20 |
| CA2891457A1 (en) | 2014-03-06 |
| CN104602671A (zh) | 2015-05-06 |
| EP2891483A4 (en) | 2016-05-04 |
| US9713610B2 (en) | 2017-07-25 |
| EP2891483A1 (en) | 2015-07-08 |
| JP2015526512A (ja) | 2015-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020008777A (es) | Inmunoterapias relacionadas con el microbioma. | |
| MX355038B (es) | Compuestos aromáticos multisustituidos como inhibidores de trombina. | |
| WO2009137465A3 (en) | Compositions for treatment or prevention of pathological cardiac remodeling and heart failure | |
| JO3419B1 (ar) | مركبات بيريدوبيرازين مضادة للسرطان من خلال تثبيط إنزيمات كيناز fgfr | |
| NZ729643A (en) | Combination therapy for treating cancer | |
| PH12014501560A1 (en) | Carbamate compounds and of making and using same | |
| MX2017004618A (es) | Inhibidores de la biosintesis de sulfato de heparano para el tratamiento de enfermedades. | |
| TN2012000143A1 (en) | Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof | |
| MX2012006730A (es) | Tiazolidinadionas moderadoras de receptores activados por proliferador de peroxizoma (ppar) y combinaciones para tratamiento de enfermedades neurodegenerativas y otras enfermedades metabolicas. | |
| MX343135B (es) | Compuestos de tipo fumagilol y métodos de realización y uso de los mismos. | |
| BR112012018022A2 (pt) | inibição de sinalização axl em terapia antimetastática. | |
| PH12013502370A1 (en) | Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases | |
| UA103930C2 (ru) | Соединения и композиция для лечения паразитарных болезней | |
| WO2011017534A3 (en) | Treatment of prostate cancer | |
| PH12015500351A1 (en) | Pharmaceutical composition for treating gastro-oesophageal reflux disease | |
| BR112016027043A8 (pt) | combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer | |
| BR112013021566A2 (pt) | composto de fórmula, ou um aduto ou sal farmaceuticamente aceitável do mesmo e método de prevenção e/ou tratamento de um indivíduo que compreende a administração ao dito indivíduo uma quantidade terapeuticamente eficaz de um composto de fórmula | |
| WO2012071573A3 (en) | Materials and methods for the prevention and treatment of cancer | |
| BR112014029573A2 (pt) | fármaco para a prevenção e/ou tratamento de doença renal policística | |
| EA033237B1 (ru) | Новые производные пиразолопиримидина в качестве ингибиторов nik, фармацевтическая композиция и лекарственное средство, содержащее ее | |
| NZ741318A (en) | Compound for treating or preventing hyperuricemia or gout | |
| WO2013048158A3 (ko) | 유파틸린의 신규 용도 | |
| EA201200428A1 (ru) | Композиция и способ для лечения ожирения | |
| WO2014149139A3 (en) | Halogenopyrazoles as inhibitors of thrombin | |
| WO2014071168A3 (en) | Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients |